These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36142556)

  • 1. In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein.
    Jalily PH; Jalily Hasani H; Fedida D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication.
    Wilson L; Gage P; Ewart G
    Virology; 2006 Sep; 353(2):294-306. PubMed ID: 16815524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin.
    Jaber AA; Chowdhury ZM; Bhattacharjee A; Mourin M; Keya CA; Bhuyan ZA
    Genomics Inform; 2021 Dec; 19(4):e48. PubMed ID: 35172476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and inhibition of the SARS coronavirus envelope protein ion channel.
    Pervushin K; Tan E; Parthasarathy K; Lin X; Jiang FL; Yu D; Vararattanavech A; Soong TW; Liu DX; Torres J
    PLoS Pathog; 2009 Jul; 5(7):e1000511. PubMed ID: 19593379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
    Toft-Bertelsen TL; Jeppesen MG; Tzortzini E; Xue K; Giller K; Becker S; Mujezinovic A; Bentzen BH; B Andreas L; Kolocouris A; Kledal TN; Rosenkilde MM
    Commun Biol; 2021 Dec; 4(1):1347. PubMed ID: 34853399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.
    Park SH; Siddiqi H; Castro DV; De Angelis AA; Oom AL; Stoneham CA; Lewinski MK; Clark AE; Croker BA; Carlin AF; Guatelli J; Opella SJ
    PLoS Pathog; 2021 May; 17(5):e1009519. PubMed ID: 34003853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.
    Dey D; Borkotoky S; Banerjee M
    Comput Biol Med; 2020 Dec; 127():104063. PubMed ID: 33126128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing interactions of Vpu from HIV-1 with amiloride-based compounds.
    Rosenberg MR; Weaver LM; Casarotto MG
    Biochim Biophys Acta; 2016 Apr; 1858(4):733-9. PubMed ID: 26724207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M; Mustafa G; Mahrosh HS
    Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
    Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
    Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation.
    Yadav R; Choudhury C; Kumar Y; Bhatia A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5147-5158. PubMed ID: 33382021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
    Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
    Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
    Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
    Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.
    Takano T; Nakano K; Doki T; Hohdatsu T
    Arch Virol; 2015 May; 160(5):1163-70. PubMed ID: 25701212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
    Mandala VS; McKay MJ; Shcherbakov AA; Dregni AJ; Kolocouris A; Hong M
    Nat Struct Mol Biol; 2020 Dec; 27(12):1202-1208. PubMed ID: 33177698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.
    Ramakrishnan J; Kandasamy S; Iruthayaraj A; Magudeeswaran S; Chinnasamy K; Poomani K
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1909-1923. PubMed ID: 33512650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
    Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B
    SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
    Dhameliya TM; Nagar PR; Gajjar ND
    Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.